Non-invasive, personalized diagnosis of coronary artery disease
Cardiolens FFR-CT Pro allows for a detailed anatomical and functional evaluation of coronary arteries.
Cardiolens FFR-CT Pro allows for a detailed anatomical and functional evaluation of coronary arteries.
The FFR-CT-based technology developed by HEMOLENS allows for a detailed anatomical and functional evaluation of coronary arteries using computational fluid dynamic principles.
Cardiolens FFR-CT Pro analyzes data from two non-invasive diagnostic methods:
Capability for testing more patients with the same infrastructure
Reduced hospitalizations and related costs
Fast and safe diagnostic method
Reduced risk and improved patient comfort
Non-invasive tool to obtain quantitative functional results of stenosis severity
Improved planning of invasive procedures based on functional FFR-CT data
Reduced number of unnecessary invasive catheterizations and coronary angiographies
A technology for healthcare providers to accurately diagnose patients with suspected ischemic heart disease.
Assessment of cerebral blood flow and brain perfusion as a significant diagnostic parameter in the diagnosis and treatment of stroke and brain aneurysms (in development).
Evaluation of hepatic, renal and cerebral blood flow and angiogenesis levels as a tool in planning optimal radio- and chemotherapy (in development).
Evaluation of pulmonary blood flow as an important diagnostic factor in the prevention and diagnostics of lung diseases (in development).
Assessment of blood flow in large vessels such as the aorta or femoral artery is an important prognostic of thrombotic lesions and a useful tool in planning the surgical treatment of embolisms (in development).
Quality Management System certificate of compliance with European Standard PN-EN ISO 13485:2016 and Medical Device Certificate in accordance with Directive 93/42/EEC.
